Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
David Gamm
Children's Hosp of Philadelphia, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Cellular Dynamics International, Inc
Other : Consulting
See attached
Retinal disease models for translational photoreceptor replacement
PROJECT NARRATIVE: Retinal degenerations are a large group of eye diseases that cause blindness. We are studying approaches to replace retinal photoreceptors derived from stem cells in retinal photoreceptor degeneration models. We will develop a regenerative medicine strategy that will provide a platform for future translational studies aimed at moving retinal therapy toward clinical trials in human patients.
Filed on November 19, 2018.
Tell us what you know about David Gamm's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
David Gamm filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| David Gamm | Johns Hopkins University | Conflict of Interest | Opsis Therapeutics, LLC | $100,000 - $149,999 |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Opsis Therapeutics, LLC | $100,000 - $149,999 |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Opsis Therapeutics, LLC | $80,000 - $99,999 |
| David Gamm | Children's Hosp of Philadelphia | Conflict of Interest | Opsis Therapeutics, LLC | $60,000 - $79,999 |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Opsis Therapeutics, LLC | $60,000 - $79,999 |
| David Gamm | Johns Hopkins University | Conflict of Interest | Opsis Therapeutics, LLC | $60,000 - $79,999 |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Opsis Therapeutics, LLC | $0 - $4,999 |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Opsis Therapeutics, LLC | $0 - $4,999 |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Cellular Dynamics International, Inc | Value cannot be readily determined |
| David Gamm | Johns Hopkins University | Conflict of Interest | Opsis Therapeutics, LLC | Value cannot be readily determined |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Opsis Therapeutics, LLC | Value cannot be readily determined |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Cellular Dynamics International, Inc | Value cannot be readily determined |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Cellular Dynamics International, Inc | Value cannot be readily determined |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Opsis Therapeutics, LLC | Value cannot be readily determined |
| David Gamm | Johns Hopkins University | Conflict of Interest | Cellular Dynamics International, Inc. | Value cannot be readily determined |
| David Gamm | University of Wisconsin Madison | Conflict of Interest | Opsis Therapeutics, LLC | Value cannot be readily determined |
| David Gamm | Children's Hosp of Philadelphia | Conflict of Interest | Opsis Therapeutics, LLC | Value cannot be readily determined |
| David Gamm | Children's Hosp of Philadelphia | Conflict of Interest | Opsis Therapeutics, LLC | Value cannot be readily determined |
| David Gamm | Johns Hopkins University | Conflict of Interest | Opsis Therapeutics, LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.